Wang Wei on China’s Overseas Acquisition Boom and the Syngenta Deal

张小珺 introduces an episode about the surge in overseas acquisitions by Chinese companies. Her guest, 王威, worked on investment, acquisitions and capital operations at Sinochem. The conversation was recorded the summer before publication and does not address later developments.

Wang began his career in due diligence and valuation at an accounting firm, joined Sinochem in 2009 and later became CFO of Meihua Biology. He subsequently served as a vice president and board secretary at a Fortune 500 company.

Asked about foreign, state-owned and private employers, Wang says his comparisons reflect his own experience. Large companies all need management systems, but decision processes, job boundaries and responses to leaders can differ.

He says some foreign firms have relatively clear job boundaries. In Chinese companies he has worked for, leaders may ask employees to handle duties outside their normal role and decisions can be more centralized. This is his generalization, not a description of every firm.

Wang says the organizational and interpersonal environment of a state-owned company can involve more considerations, while its employee protections may differ. He also acknowledges that foreign companies can have complex internal relationships at senior levels.

In his experience, private firms may adjust decisions and roles more flexibly but depend more heavily on the person in charge. Cross-functional rotations in state-owned firms can help develop managers, while foreign firms more often follow professional specialization.

On the practice of carrying a leader’s bag, he says supporting a superior is an extra part of a job, not a substitute for professional ability. The host then turns to overseas acquisitions.

Wang distinguishes corporate M&A from common VC and PE investments. A company often acquires to advance strategic goals such as market position, technology or access, and may seek control and take part in management. A financial investor more often focuses on appreciation and eventual exit.

He stresses that these are common patterns rather than absolute rules: companies can buy minority stakes and funds can make controlling acquisitions. The transaction form alone does not establish the motive.

As an example, a steel producer might invest in a mine for a minority stake in exchange for a share of long-term supply and price protection. The investment serves its supply chain as well as financial goals.

A fund, conversely, might buy a business and use it as a platform for further acquisitions, growing it before exit. He cites the restructuring and separation of Belle’s businesses as an example.

Wang says practitioners often describe 2009–2017 as a period of particularly active Chinese overseas M&A, although such investment began in the 1990s. Earlier transactions were generally smaller because companies had less capital and scale.

He identifies a 2009 public statement encouraging Chinese companies, especially central state-owned enterprises, to undertake cross-border acquisitions as a clear policy marker. Some firms had already begun acting before that statement, he adds.

Asked why buy instead of building abroad, Wang says buying a mature business exchanges capital for time: it brings an existing market, operation and staff, while building from scratch can take years and still fail.

Financially, he says, an acquisition can turn balance-sheet resources such as cash into revenue and profits, though the buyer must still assess strategic fit and price.

Wang recalls that overseas sellers initially knew little about Chinese companies and some wanted to sell non-core businesses. He believes a willingness to retain existing managers could affect sellers’ attitudes; this is one practitioner’s observation.

He identifies Lenovo’s purchase of IBM’s PC business and Geely’s acquisition of Volvo Cars as pioneering deals. The former preceded the wave and the latter came near its beginning; neither buyer then had its present global scale.

In his account both sold businesses faced challenges: IBM wanted to transform and divest personal computers, while Volvo Cars had previously belonged to Ford. The market doubted whether Chinese buyers could take over and integrate them.

Wang says criticism that a deal was expensive usually concerns valuation relative to profits or assets, not just its absolute price. With the same purchase price, lower profits imply a higher price-to-earnings multiple.

Another concern was whether the acquired business might burden the buyer. Wang believes years of integration improved both buyers’ international scale and competitiveness; this is his assessment of the outcomes.

Using Geely as an example, he says Volvo’s technology and brand gave it an opportunity to learn, while Volvo gained access to the Chinese market. He discusses brand positioning, family vehicles and safety, and changes in product quality.

He believes sellers may welcome a buyer willing to retain management. Unlike deals seeking synergies through layoffs or management changes, Chinese buyers unfamiliar with overseas markets often needed existing teams to continue running operations.

Wang likens a deal to marriage: the public may focus on the announcement, but for the buyer the long-term result depends on whether the parties can operate together after closing. People, operations and cultures all need time to adjust.

He believes Lenovo and Geely sought not only profits but technology, brands and competitive capability. Lenovo emphasized supply chains and localization, while Geely wanted to bring Volvo into China and improve its own R&D and manufacturing.

On culture, he says neither company simply required overseas teams to adopt Chinese practices wholesale; both tried to build global operations. In his view, accommodating different cultures is essential to integration.

How should a buyer judge a target? Wang repeats the industry saying that there are no bad deals, only bad prices, but stresses that a company must first define its strategic goal. A transaction can be suitable when the price makes sense and it solves the buyer’s problem.

He attributes the acquisition wave to several factors: economic growth and globalization, stronger companies, demand for technology and resources, and policy and financial support. This is his analysis, not a claim that one cause explains every deal.

He adds that overseas investment involved development, foreign-exchange and commerce approvals, with additional procedures for state-owned enterprises. Bank financing also supported large transactions, alongside target assessment and institutional requirements.

Wang says he happened to join Sinochem’s M&A team in 2009. The period created corporate demand for specialists, and he gained experience through it.

He describes the energy, chemical and agricultural businesses the team studied. Agricultural inputs include seeds, crop protection and fertilizer, and a target must fit a company’s business and strategy.

He recalls that Syngenta was initially viewed as a high-quality industry asset that was expensive and difficult to approach. The team also examined producers of off-patent agricultural chemicals, whose margins and valuations generally differed from those with proprietary patents.

Asked what later made the Syngenta deal possible, Wang points to stronger Chinese companies, changes in the industry and sellers’ views of the Chinese market. This is his explanation.

He argues that assessing Syngenta requires looking beyond the absolute price to its R&D, technology, market position and the buyer’s goals. His specific estimates of the technology gap are personal judgments.

He says Chinese buyers gradually gained transaction experience and were increasingly seen as participants with capital and a desire to acquire. He recalls encountering arrogance in negotiations, but says professional communication gradually improved the reception.

On the approximately $43 billion Syngenta transaction, Wang says large cross-border deals often take a long time. The 2016 announcement by Syngenta and the acquirer identifies China National Chemical Corporation, or ChemChina, as the buyer; Sinochem and ChemChina merged later.

Buying a company is not like buying an ordinary product, he warns. Environmental contamination, tax issues, labor disputes and potential litigation can create obligations and costs that continue for years after closing.

Wang divides corporate M&A into four stages: set strategy, select a target, execute the transaction and integrate after closing. The execution stage draws the most public attention because bankers, lawyers, accountants and public-relations teams all become involved.

He considers strategy the starting point. A company must first decide whether it wants to enter an industry, acquire technology or reach another goal, then choose acquisition as a means. Long-term ownership and a short-term exit lead to different paths.

Target selection rarely produces a perfect match. Every company has a price, strengths and risks, and executives can weigh risks and returns differently; they may even reconsider building the business themselves.

He likens execution to a wedding: professional advisers help with much of the work. A corporate buyer typically assesses commercial operations, production, finance, tax, law, environment, health, safety and human resources.

Due diligence is also limited by how much information the seller opens. A listed company may not disclose all sensitive material. Wang argues that buyers cannot delegate their judgment entirely to advisers who participate for only a month or two.

He says some large transactions have preliminary agreements before due diligence, potentially including a fee if the deal is terminated; due diligence itself also costs money. Buyers therefore usually have an initial view of the business before reaching this stage.

Post-acquisition integration covers people, operations, management and culture. Wang says compliance with local law, employee retention and collaboration determine whether the strategy is realized; he treats integration as equally important to the pre-deal work.

Wang considers Syngenta a company with strong research and technology. On the roughly $43 billion price, he says the acquisition premium, control and long-term value must be considered together. He views the price as understandable, but that is his assessment.

Sellers’ boards and shareholders have their own price expectations, he notes, so a low market price does not guarantee a cheap purchase. The deal also needed financing support from state-owned and foreign banks.

Wang recalls that negotiations involved more than price: gaining trust, retaining researchers and managers, and deciding how the Chinese and Swiss businesses could develop together. The seller also considered whether remaining independent would create more value.

Integration cannot be finished in a few months, he says. The initial months are a transition in which people, systems and rules begin to connect; a shared direction and sustained cooperation take longer.

He identifies key challenges as retaining managers and scientists who understand global markets and preserving international operations while meeting Chinese state-owned enterprise management requirements.

Wang sees the Syngenta deal as both a peak and a turning point for the acquisition wave. He argues that external reviews, geopolitics and changes in globalization constrained later deals, and also mentions failed investments and capital outflows.

He cites HNA’s diversified acquisitions and argues that purchases should serve a clear strategy. Outsiders cannot assess every synergy, but a weak connection between target and business raises questions about strategic logic.

Other examples he cites include CNOOC’s acquisition of Nexen, a Minmetals investment in a Peruvian copper mine and Anta’s participation in the acquisition of Amer Sports. He says resources were a major part of Chinese overseas M&A.

He says professional specialists can assess mineral and oil reserves, while valuation also depends on long-term commodity prices. A technology company, by contrast, depends more on researchers, making retention crucial.

On Anta and Amer Sports, he believes a portfolio of international brands helped expand markets and positioning. He views these deals as different paths by which Chinese companies learned to operate globally.

How should success or failure be judged? Wang says outsiders’ views of whether a deal was cheap or expensive are insufficient; one must return to the buyer’s original goal. A deal may have failed if existing problems remain and burden the acquirer.

He believes domestic M&A culture differs from overseas deals because of factors including founder control, state-asset valuation and governance. Overseas sellers may also weigh price and whether managers can stay. These are his observations.

He believes overseas acquisitions expanded Chinese companies’ assets, global operations and experience, but says whether a similar wave can recur depends on a different external environment.

He summarizes the era in terms of Chinese capital, globalization and growth: companies expanded, while practitioners gained perspective and professional skills by working with international businesses.

Cross-border M&A teams must use two working languages, Wang says: negotiating with sellers and advisers abroad while presenting the case internally through their own company’s decision process. The work is demanding and spans time zones.

He recalls an Australian deal in 2009. The initial assessment found a strategic fit, and the parties began talks in spring. Price negotiations lasted months before a preliminary agreement and due diligence.

At one meeting the parties were one dollar per share apart, and the seller’s founder briefly walked out. The buyer later assessed potential synergies and concluded that some premium could be justified, bringing the price expectations closer.

During due diligence the team coordinated Australian, Chinese and other time zones. Wang recalls sleeping only a few hours at a time while checking the business and risks with teams in several regions.

Due diligence identified potential environmental, tax, litigation and financial issues. The team believed these should affect the valuation and sought a lower price. The seller rejected it, brought in another investor and the transaction did not close.

He recalls answers from some managers that troubled him: on environmental liabilities they sometimes simply said there would be no problem, while some financial explanations did not satisfy the buyer. Wang saw these as signals requiring further investigation.

He describes another transaction involving a European company. After the buyer agreed to purchase part of a business, the seller changed an accounting treatment of asset impairments, affecting future depreciation and profits and thus the buyer’s valuation.

Wang says the parties disputed the issue for about two months and ultimately revisited the accounting. If the price stays fixed while future profit falls, he explains using a price-to-earnings multiple, the effective valuation rises.

A cross-border team must also explain different valuation languages. Wang says external discussions often use discounted cash flow and enterprise value to EBITDA, while internal managers may be more familiar with price-to-earnings and price-to-book.

His approach is to use the metrics familiar to each audience and have the team understand and translate the differences. Advisers provide expertise, but cannot replace internal staff’s understanding of what decision-makers care about.

His first advice to later practitioners is to define the purpose of the deal rather than follow others into acquisitions. Once a strategy is set it should be tested, but the team should not lose direction simply because other options appear.

Few targets fit a checklist perfectly: advantages and drawbacks often come together. Teams should discuss risks, returns and trade-offs rather than focus on one attractive feature or price.

He urges buyers to take part directly in due diligence rather than delegate all judgment to an investment bank. Some advisers are paid when a deal closes and may have different incentives; buyers need independent understanding before deciding.

Finally, he says contracts and legal terms deserve close attention; buyers should not assume everything can be renegotiated after signing. When problems emerge, assess their impact on operations, risk and price and renegotiate if necessary rather than ignoring them.